Hypertriglyceridemia: Clinical Trials

96 trials for Hypertriglyceridemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

66 completed, 12 unknown, 5 active not recruiting, 5 terminated. 96 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable96Completed 66, Unknown 12, Active not recruiting 5, Terminated 5, Not yet recruiting 3, Recruiting 3, Enrolling by invitation 1, Withdrawn 1

Follow Hypertriglyceridemia: new trials by email Literature Review of Hypertriglyceridemia trials Research Report on Hypertriglyceridemia

Trials (filtered) newest first · largest first

All 96 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Plasma Lipids-Dependent Vitamin E Metabolism During Dynamic Hyperlipidemia
High fat liquid shake - Lipid Metabolism Disorders
Not applicableNot yet recruitingNational Heart, Lung, and Blood Institute (NHLBI)482026-11-112026-11-06
Comparing Two Low-Carbohydrate Diets With a Standard Diet in Type 2 Diabetes
High-Protein Low-Carbohydrate Diet, High-Fat Low-Carbohydrate Diet, Standard diet - Diabete Mellitus, Obesity & Overweight
Not applicableNot yet recruitingNational Nutrition and Food Technology Institute1682026-09-202026-09-08
Standardized Large Yellow Tea Extract for Glucose and Lipid Metabolism in Overweight Adults With Hypertriglyceridemia
Standardized Large Yellow Tea Extract, Placebo - Hypertriglyceridemia, Overweight , Obesity
Not applicableNot yet recruitingThe First Affiliated Hospital of China University of Science and Technology (Anhui Provincial)1382026-09-012026-09-25
Pemafibrate for Symptomatic ICAS RCT
Pemafibrate - Intracranial Atherosclerotic Disease (ICAD), Hypertriglyceridaemia
Not applicableRecruitingTokyo Women's Medical University2702026-05-262026-11-03
WB-EMS Effects on Cardiometabolic Risk Factors
WB-EMS, Control - Hypertension, Metabolic Syndrome
Not applicableActive not recruitingUniversity of Erlangen-Nürnberg Medical School282026-02-152026-05-14
Limosilactobacillus Fermentum CRL 1446 - CONICET CASASCO
Limosilactobacillus fermentum 1446 CRL CONICET 2.20E+9 CFU, Placebo (inert excipient) - Disbiosis, Obesity
Not applicableActive not recruitingPINER Pastor Manfredi Winery802026-02-022026-05-14
Effect of Consuming n-3 Polyunsaturated Fatty Acids Rich Foods on Triglyceride Concentration and Lipoprotein Composition
Isocaloric diet including chia and pumpkin seeds, Isocaloric diet - Hypertriglyceridemia
Not applicableRecruitingInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran3752026-02-012026-04-14
A Trial to Evaluate the Efficacy and Safety of DR10624 in Patients With Hypertriglyceridemia and Carotid Atherosclerotic Plaque
DR10624 Injection;, DR10624 Injection Placebo (referred to as placebo) - Hypertriglyceridemia, Carotid Atherosclerotic Plaques
Not applicableEnrolling by invitationJunbo Ge402025-07-012026-06-17
Comparison of Cardiometabolic Markers in Individuals With Hypertriglyceridemia With Low and High Weight Loss Responses to an Energy-restricted Diet
Low-calorie diet - Obesity and Overweight, Hypertriglyceridaemia
Not applicableCompletedShahid Beheshti University of Medical Sciences602025-06-102026-01-28
Cardiometabolic Properties of Omega-3 Functionalized With Hydroxytyrosol
EPA + HT, EPA, Sunflower Oil - Hypertriglyceridemia, Normal
Not applicableActive not recruitingNational Research Council, Spain682025-02-172025-05-28
Evaluation of the Efficacy of Phospholipid-Bound Omega-3 Versus Omega-3 Alone in Patients With Hypertriglyceridemia: A Randomized Clinical Trial
Intervention Arm: Omega-3 + Phospholipids., Comparator Arm: Omega-3 alone. - Hypertriglyceridemia
Not applicableActive not recruitingFundación del Caribe para la Investigación Biomédica442024-12-172025-07-17
Barberry and Cardiometabolic Risk Factors in Individuals With Hypertriglyceridemia
Dried barberry, Low-calorie diet - Hyperlipidemias, Hypertriglyceridemia
Not applicableCompletedShahid Beheshti University562024-09-092025-05-06
Rosemary Infusion for Hypertension With Hypertriglyceridemia
Rosemary infusion, rosemary infusion - Hypertension With Hypertriglyceridemia
Not applicableCompletedawatef Sassi472024-09-012026-01-20
Exploring Physical Exercise for the Regulation and Control of Metabolic Disorders in College Students.
Physical exercise prescription: Continuous aerobic training (jogging, swimming, static cycling), Control group: Continuous aerobic physical exercise - Metabolic Disorders, Abdominal Obesity
Not applicableUnknownUniversidad de Colima482024-09-012024-08-15
Response to an Intervention With Omega-3 (RIO - Study)
Omega-3, HOSO - Overweight, Hypertriglyceridemia
Not applicableCompletedUniversidad San Sebastián402024-07-302025-09-25
Culturally Adapted Dietary Clinical Trial in PR
Culturally tailored food and diet advice, Standard healthy eating advice - Diabetes Mellitus, Type 2, Obesity
Not applicableRecruitingHarvard School of Public Health (HSPH)2502024-05-022026-07-28
A Study on the Effects of Mastiha Oil in Adults With Hypertriglyceridemia
MastihaOil, nutritional counsel - Hypertriglyceridemia
Not applicableUnknownHarokopio University1002024-04-012024-03-21
Metabolic Heterogeneity Underlying Hypertriglyceridemia: Hepatic Triglyceride Biosynthesis in Humans With Different Insulin Resistance Phenotypes
Standardized Dinner, Premeal exercise - Insulin Resistance, Hypertriglyceridemia
Not applicableTerminatedYale University82023-11-162026-10-27
Chia Seeds Consumption in Hypertriglyceridemia
Control, Omega-3 supplementation, Chia seed - Hypertriglyceridemia
Not applicableCompletedShahid Beheshti University662023-09-182024-03-19
Effect of Silibinin(A) as a Potential Anti-obesity Agent
Silibinin A - Overweight and Obesity, Hypercholesterolemia
Not applicableUnknownUniversidad Católica San Antonio de Murcia602023-01-122023-06-23

Showing 20 of 96. Sign in to see all of them.

Narrower conditions

Obesity (19)  ·  Metabolic Syndrome (16)  ·  Hypertension (13)  ·  Insulin Resistance (12)  ·  Overweight (12)  ·  Hypercholesterolemia (11)  ·  Diabetes Mellitus (10)  ·  Dyslipidemias (9)  ·  Hyperglycemia (8)  ·  Hyperlipidemias (8)  ·  Cardiovascular Diseases (7)  ·  Obesity, Abdominal (7)  ·  Inflammation (6)  ·  HIV Infections (5)

Broader conditions

Nutritional and Metabolic Diseases (96)  ·  Lipid Metabolism Disorders (93)  ·  Metabolic Diseases (93)  ·  Hyperlipidemias (88)  ·  Dyslipidemias (87)  ·  Glucose Metabolism Disorders (37)  ·  Pathological Conditions, Signs and Symptoms (35)  ·  Signs and Symptoms (32)  ·  Body Weight (28)  ·  Nutrition Disorders (28)  ·  Overnutrition (28)  ·  Hyperinsulinism (23)  ·  Vascular Diseases (17)  ·  Overweight (16)  ·  Cardiovascular Diseases (15)

Interventions

Diet (6)  ·  Fish Oils (5)  ·  Caloric Restriction (3)  ·  Docosahexaenoic Acids (3)  ·  Exercise (3)  ·  Fructose (3)  ·  Omacor (3)  ·  Fenofibrate (2)  ·  Glucose (2)  ·  Niacin (2)  ·  Nutrition Assessment (2)  ·  Soybean Oil (2)  ·  soybean oil, phospholipid emulsion (2)  ·  (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid (1)  ·  Amino Acids (1)

Sponsors

Montana State University (5)  ·  Midwest Center for Metabolic and Cardiovascular Research (3)  ·  Shahid Beheshti University (3)  ·  Stanford University (3)  ·  Baylor College of Medicine (2)  ·  Harvard School of Public Health (HSPH) (2)  ·  Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (2)  ·  National Heart, Lung, and Blood Institute (NHLBI) (2)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (2)  ·  Penn State University (2)  ·  University of Arizona (2)  ·  University of Arkansas (2)  ·  University of Jena (2)  ·  Yale University (2)  ·  Amorepacific Corporation (1)

Countries

United States (39)  ·  France (5)  ·  Germany (4)  ·  Iran (4)  ·  Spain (4)  ·  Canada (3)  ·  Italy (3)  ·  Mexico (3)  ·  Puerto Rico (3)  ·  China (2)  ·  Japan (2)  ·  South Korea (2)  ·  Argentina (1)  ·  Australia (1)  ·  Chile (1)

Top investigators

Mary P Miles, PhD (3)  ·  Christopher D Gardner (2)  ·  Josiemer Mattei, PhD, MPH (2)  ·  Kevin Maki, PhD (2)  ·  Penny M Kris-Etherton, PhD (2)  ·  Robert Benamouzig (2)  ·  Abhimanyu Garg, MD (1)  ·  Amarilys F Sylva, PhD (1)  ·  Andrea Natali, MD (1)  ·  Angelo Tremblay (1)  ·  Ann C Skulas-Ray, B.S. (1)  ·  Ashok Balasubramanyam, MD (1)  ·  Belong Cho, MD, PhD (1)  ·  Benedicto Crespo-Facorro, Professor (1)

Results publications

PMID 12485966, PMID 16530201, PMID 16818923, PMID 16940448, PMID 17384344, PMID 17684201, PMID 18156400, PMID 18327998, PMID 18541599, PMID 20495438, PMID 21159789, PMID 21502576, PMID 21565796, PMID 21775113, PMID 21775114, PMID 21924882, PMID 21999398, PMID 22031659, PMID 22041543, PMID 22170364, PMID 22170723, PMID 22865498, PMID 23299761, PMID 23522788, PMID 23592752, PMID 23640486, PMID 24239923, PMID 24279738, PMID 24528690, PMID 25123060, PMID 25216712, PMID 25527677, PMID 25559009, PMID 26499033, PMID 27281799, PMID 27281800, PMID 27490922, PMID 27548405, PMID 27600795, PMID 27614801, PMID 27807041, PMID 27910077, PMID 28515160, PMID 29426328, PMID 29808092, PMID 30049591, PMID 30451147, PMID 32652034, PMID 32865503, PMID 32977252

NIH funding

R01AG033761 (1), R01DK124272 (1), R01HD040787 (1), R01HL073696 (1), R21AT003465 (1), R21HL073675 (1), R56HL118343 (1)